Broker Tips
Markets underestimate potential for Covid-19 therapies to support re-opening US economy
The road to re-opening America's economy will be "long" and the final destination will only be reached when a vaccine for the Covid-19 coronavirus is found, analysts at Morgan Stanley warned.
Liberum nudges up price target on National Express
Analysts at Liberum raised their target price on National Express from 400. 0p to 425. 0p on Tuesday, highlighting the firm's ability to remaining earnings and cash flow positive and its extra liquidity headroom.
Broker tips: Smith & Nephew, Halma, National Express
Analysts at Citi downgraded their view for shares of medical device maker Smith & Nephew to 'neutral' in anticipation of six to 18 months of difficult trading in the wake of the Covid-19 pandemic.
Berenberg lowers target price on Halma
Analysts at Berenberg lowered their target price on hazard detection technology group Halma from 1,860. 0p to 1,710. 0p on Tuesday, flagging some near-term concerns to clients even as they conceded that there were longer-term opportunities on offer.
Citi downgrades Smith and Nephew to 'neutral'
Analysts at Citi downgraded their view for shares of medical device maker Smith&Nephew to 'neutral' in anticipation of six to 18 months of difficult trading in the wake of the Covid-19 pandemic.
'V is for Vaccine', BofA says
Strategists at Bank of America still saw scope for one more leg up in equities due to investors' still "very bearish" positioning.
Tuesday broker round-up
Smith & Nephew: Citigroup downgrades to neutral with a target price of 1,700p.